Cargando…

Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research

Coronavirus disease 2019 (COVID-19) was declared to be a global pandemic by the World Health Organization on March 11, 2020. On April 7, 2020, a state of emergency was declared in Japan, as had been by other nations worldwide. This unprecedented crisis has profound implications for patients undergoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahari, Daisuke, Shinozaki, Eiji, Wakatsuki, Takeru, Ooki, Akira, Ozaka, Masato, Suzuki, Takeshi, Nakayama, Izuma, Osumi, Hiroki, Kamiimabeppu, Daisaku, Sato, Taro, Ogura, Mariko, Suenaga, Mitsukuni, Chin, Keisho, Yamaguchi, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576109/
https://www.ncbi.nlm.nih.gov/pubmed/33085057
http://dx.doi.org/10.1007/s10147-020-01806-7
_version_ 1783597949539844096
author Takahari, Daisuke
Shinozaki, Eiji
Wakatsuki, Takeru
Ooki, Akira
Ozaka, Masato
Suzuki, Takeshi
Nakayama, Izuma
Osumi, Hiroki
Kamiimabeppu, Daisaku
Sato, Taro
Ogura, Mariko
Suenaga, Mitsukuni
Chin, Keisho
Yamaguchi, Kensei
author_facet Takahari, Daisuke
Shinozaki, Eiji
Wakatsuki, Takeru
Ooki, Akira
Ozaka, Masato
Suzuki, Takeshi
Nakayama, Izuma
Osumi, Hiroki
Kamiimabeppu, Daisaku
Sato, Taro
Ogura, Mariko
Suenaga, Mitsukuni
Chin, Keisho
Yamaguchi, Kensei
author_sort Takahari, Daisuke
collection PubMed
description Coronavirus disease 2019 (COVID-19) was declared to be a global pandemic by the World Health Organization on March 11, 2020. On April 7, 2020, a state of emergency was declared in Japan, as had been by other nations worldwide. This unprecedented crisis has profound implications for patients undergoing chemotherapy and for practicing healthcare professionals. Various reports have shown data indicating that cancer patients with COVID-19 have high morbidity and mortality rates. In order to reduce the use of medical resources to avoid the risk of COVID-19 infections in both cancer patients and health care providers, oncologists now have to draw the line for cancer treatments by maintaining their efficacy while avoiding severe adverse events. In this article, we outlined the decisions made regarding the practice of gastrointestinal oncology in our institution during the COVID pandemic.
format Online
Article
Text
id pubmed-7576109
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-75761092020-10-21 Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research Takahari, Daisuke Shinozaki, Eiji Wakatsuki, Takeru Ooki, Akira Ozaka, Masato Suzuki, Takeshi Nakayama, Izuma Osumi, Hiroki Kamiimabeppu, Daisaku Sato, Taro Ogura, Mariko Suenaga, Mitsukuni Chin, Keisho Yamaguchi, Kensei Int J Clin Oncol Original Article Coronavirus disease 2019 (COVID-19) was declared to be a global pandemic by the World Health Organization on March 11, 2020. On April 7, 2020, a state of emergency was declared in Japan, as had been by other nations worldwide. This unprecedented crisis has profound implications for patients undergoing chemotherapy and for practicing healthcare professionals. Various reports have shown data indicating that cancer patients with COVID-19 have high morbidity and mortality rates. In order to reduce the use of medical resources to avoid the risk of COVID-19 infections in both cancer patients and health care providers, oncologists now have to draw the line for cancer treatments by maintaining their efficacy while avoiding severe adverse events. In this article, we outlined the decisions made regarding the practice of gastrointestinal oncology in our institution during the COVID pandemic. Springer Singapore 2020-10-21 2021 /pmc/articles/PMC7576109/ /pubmed/33085057 http://dx.doi.org/10.1007/s10147-020-01806-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Takahari, Daisuke
Shinozaki, Eiji
Wakatsuki, Takeru
Ooki, Akira
Ozaka, Masato
Suzuki, Takeshi
Nakayama, Izuma
Osumi, Hiroki
Kamiimabeppu, Daisaku
Sato, Taro
Ogura, Mariko
Suenaga, Mitsukuni
Chin, Keisho
Yamaguchi, Kensei
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research
title Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research
title_full Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research
title_fullStr Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research
title_full_unstemmed Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research
title_short Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research
title_sort managing a gastrointestinal oncology practice in japan during the covid-19 pandemic: single institutional experience in the cancer institute hospital of japanese foundation for cancer research
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576109/
https://www.ncbi.nlm.nih.gov/pubmed/33085057
http://dx.doi.org/10.1007/s10147-020-01806-7
work_keys_str_mv AT takaharidaisuke managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT shinozakieiji managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT wakatsukitakeru managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT ookiakira managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT ozakamasato managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT suzukitakeshi managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT nakayamaizuma managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT osumihiroki managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT kamiimabeppudaisaku managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT satotaro managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT oguramariko managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT suenagamitsukuni managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT chinkeisho managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch
AT yamaguchikensei managingagastrointestinaloncologypracticeinjapanduringthecovid19pandemicsingleinstitutionalexperienceinthecancerinstitutehospitalofjapanesefoundationforcancerresearch